Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
The Winship Cancer Institute received a $7.9 million, 5-year grant from the NCI to study cell signaling in lung cancer
In 2006, the Winship Cancer Institute received a $7.9 million P01 5-year grant from the Cancer Institute (NCI)…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA)Â announced it had approved Genentech’s drug Tarceva…
NCI launched the National Lung Screening Trial to compare two ways of testing for early lung cancer in current and former heavy smokers
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
The National Cancer Institute launched the National Lung Screening Trial
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
Court of Appeals ruled commercial success does not constitute substantial evidence of drug safety and efficacy
On Feb. 27, 1970, in Upjohn v. Finch the Court of Appeals upheld enforcement of the 1962 drug…
World’s first succesful surgical lung removal was performed at Washington University – St Louis
On Apr. 4, 1933, Evarts A. Graham, MD at Washington University – St. Louis performed the world’s first…